Oral and Skin Pigmentations associated with hydroxyurea therapeutic doses in a patient with sickle cell disease: Case Report
DOI:
https://doi.org/10.51984/joms.v18i1.2606Keywords:
Sickle cell Disease, Hydroxyurea, Hyperpigmentation, Oral CavityAbstract
Hydroxyurea is an effective treatment for Sickle cell disease. Hydroxyurea has classified as an antineoplastic agent and is also prescribed as Antisickling agent; it works through inhibition of DNA synthesis at S phase. Despite Hydroxyurea benefits sickle cell patients, undesirable side effect such as leukopenia and hyperpigmentation were observed. Hydroxyurea-induced hyperpigmentation is mainly seen in the skin and rarely in the oral cavity. Although Hydroxyrea-induced pigmentation is benign and reversible, this mild pathological condition should have considered.
Downloads
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2023 Journal of Medical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This article is published open access under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). You may copy, redistribute, adapt and build upon it for non-commercial purposes, provided you credit the authors, cite the original publication in the Journal of Medical Sciences with its DOI, indicate any changes, and distribute any adaptations under the same licence. Copyright rests with the authors. For commercial reuse, please contact the corresponding author. Full terms: https://sebhau.edu.ly/journal/joms/copyright-licensing




















